MUCICLAR*NEBUL 30 VIALS 15MG 2ML

MUCICLAR 15 mg/2 ml nebuliser solution
Ambroxol hydrochloride
Equivalent medicine

What it is and what it is used for
This medicine contains the active ingredient ambroxol hydrochloride, belonging to a group of medicines called mucolytics, used to facilitate the elimination of mucus from the respiratory tract.

MUCICLAR is indicated for the treatment of secretions in acute and chronic bronchial and lung diseases (in the presence of cough and phlegm).

Contact your doctor if you do not feel better or if you feel worse.

What you need to know before taking the medicine
Do not take MUCICLAR
- if you are allergic to ambroxol hydrochloride or any of the other ingredients of this medicine (listed in section 6);
- if you suffer from severe liver or kidney problems.

Warnings and precautions
Talk to your doctor or pharmacist before taking MUCICLAR.

Take this medicine with caution and inform your doctor:
- if you suffer from a stomach or intestinal problem called peptic ulcer;
- if you suffer from kidney problems (renal insufficiency).
Cases of severe skin reactions associated with ambroxol administration have been reported. If you develop a skin rash (including lesions of mucous membranes such as the mouth, throat, nose, eyes, genitals), stop taking MUCICLAR and contact your doctor immediately.
Especially in the initial phase of these diseases, you may experience flu-like symptoms, such as fever, pain, cold (rhinitis), cough and sore throat.
During the administration of the nebuliser solution, an irritation cough may occur; it is advisable to breathe normally during inhalation. If you are particularly sensitive to this condition, it is advisable to heat the solution to body temperature (37°C) before inhalation.
If you suffer from asthma, it is advisable to take asthma medication (bronchospasmolytics) before using this medicine by inhalation.

Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects may occur:

Common (may affect up to 1 in 10 people)
- altered sense of taste (dysgeusia);
- loss of sensitivity (hypoesthesia) of the oral cavity and pharynx;
- nausea.

Uncommon (may affect up to 1 in 100 people)
- vomiting, diarrhoea, indigestion (dyspepsia) and abdominal pain;
- dry mouth.

Rare (may affect up to 1 in 1000 people)
- headache;
- increased mucus production, runny nose (rhinorrhoea);
- heartburn and oesophagitis (pyrosis);
- constipation;
- skin irritation (rash, urticaria, contact dermatitis);
- difficulty in urinating (dysuria);
- fatigue.
- hypersensitivity reactions

Not known (frequency cannot be estimated from the available data)
- anaphylactic reactions, including anaphylactic shock, angioedema (rapidly developing swelling of the skin, subcutaneous tissues, mucous membranes and submucosal tissues), pruritus and other hypersensitivity reactions;
- severe cutaneous adverse reactions (including erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis and acute generalised exanthematous pustulosis)
- bronchial occlusion (bronchial obstruction);
- dry throat.

Reporting of side effects
If you get any side effects, including any not listed in this leaflet, tell your doctor or pharmacist. You can also report side effects directly via the national reporting system at: https://www.aifa.gov.it/content/segnalazionireazioni-avverse.
By reporting side effects you can help provide more information on the safety of this medicine.